36.17
1.06%
0.38
After Hours:
36.17
Atricure Inc stock is traded at $36.17, with a volume of 269.65K.
It is up +1.06% in the last 24 hours and up +29.50% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
See More
Previous Close:
$35.79
Open:
$36.14
24h Volume:
269.65K
Relative Volume:
0.49
Market Cap:
$1.75B
Revenue:
$447.57M
Net Income/Loss:
$-38.92M
P/E Ratio:
-66.98
EPS:
-0.54
Net Cash Flow:
$-1.15M
1W Performance:
+0.39%
1M Performance:
+29.50%
6M Performance:
+55.97%
1Y Performance:
-13.88%
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
36.17 | 1.75B | 447.57M | -38.92M | -1.15M | -0.54 |
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
Sep-29-23 | Initiated | UBS | Buy |
Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
Dec-18-20 | Reiterated | Needham | Buy |
Nov-06-20 | Reiterated | Needham | Buy |
Apr-07-20 | Initiated | Oppenheimer | Outperform |
Feb-06-20 | Initiated | BTIG Research | Buy |
Jan-24-20 | Reiterated | Needham | Buy |
Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
Apr-12-19 | Initiated | JP Morgan | Overweight |
Oct-04-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Stifel | Buy |
Jun-18-18 | Reiterated | Needham | Buy |
Apr-27-18 | Reiterated | Needham | Buy |
Jan-16-18 | Reiterated | Needham | Buy |
Nov-02-17 | Reiterated | Needham | Buy |
Jul-28-17 | Reiterated | Needham | Buy |
May-30-17 | Resumed | Piper Jaffray | Overweight |
Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
Oct-28-15 | Reiterated | Needham | Buy |
Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $14.04 Million Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Buys 52,533 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Purchases Shares of 31,366 AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Trend Tracker for (ATRC) - Stock Traders Daily
AtriCure Inc. loses $24 million in value following the election (See how it affected others) - The Business Journals
AtriCure to Present at Piper Sandler Healthcare Conference in December | ATRC Stock News - StockTitan
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
AtriCure, Inc. (NASDAQ:ATRC) Receives $43.11 Average Price Target from Analysts - MarketBeat
What to Expect from AtriCure - AOL
Assetmark Inc. Has $39,000 Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Hood River Capital Management LLC Bolsters Stake in AtriCure Inc. - GuruFocus.com
Short Interest in AtriCure, Inc. (NASDAQ:ATRC) Declines By 31.6% - MarketBeat
AtriCure Inc (ATRC) Stock Price Down 3.06% on Nov 12 - GuruFocus.com
(ATRC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
AtriCure to Participate in the Stifel 2024 Healthcare Conference - StockTitan
A Piece Of The Puzzle Missing From AtriCure, Inc.'s (NASDAQ:ATRC) 28% Share Price Climb - Simply Wall St
AtriCure (ATRC) Stock Surges Over 5% Amid Market Volatility - GuruFocus.com
AtriCure Inc (ATRC) Shares Up 3.58% on Nov 5 - GuruFocus.com
Emerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday - MSN
US$42.67That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results - Simply Wall St
AtriCure, Inc. (NASDAQ:ATRC) Q3 2024 Earnings Call Transcript - Insider Monkey
AtriCure Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)? - Simply Wall St
Earnings call: AtriCure reports robust growth, raises full-year guidance By Investing.com - Investing.com Nigeria
Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation By Investing.com - Investing.com South Africa
Earnings call: AtriCure reports robust growth, raises full-year guidance - Investing.com India
AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
AtriCure price target raised to $36 from $32 at Oppenheimer - MSN
AtriCure (NASDAQ:ATRC) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation - Investing.com India
AtriCure (NASDAQ:ATRC) Shares Gap Up Following Strong Earnings - MarketBeat
AtriCure (NASDAQ:ATRC) Given New $53.00 Price Target at Canaccord Genuity Group - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Down 8.4% in October - MarketBeat
AtriCure Reports Strong Growth in Q3 2024 Earnings - TipRanks
AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - Yahoo Finance
AtriCure: Q3 Earnings Snapshot - The Washington Post
AtriCure (NASDAQ:ATRC) Releases FY 2024 Earnings Guidance - MarketBeat
AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
AtriCure Inc (ATRC) Q3 2024 Earnings: Revenue Surpasses Estimates at $115.9 Million, Net Loss Per Share at $0.17 - GuruFocus.com
AtriCure Reports Third Quarter 2024 Financial Results - Business Wire
Assenagon Asset Management S.A. Purchases 138,046 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
AtriCure to Participate in the UBS Global Healthcare Conference - Business Wire
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):